Studies related to Blood Glucose and Alpha-Lipoic Acid

Glycemic And Oxidative Status Of Patients With Type 2 Diabetes Mellitus Following Oral Administration Of Alpha-lipoic Acid: A Randomized Double-blinded Placebo-controlled Study

Effect Decrease
Trial Design Double blind
Trial Length n/a
Number of Subjects 38
Sex n/a
Notes for this study:
300, 600, 900, or 1,200mg of ALA was effective in reducing HbA1c and blood glucose over a period of 6 months in persons with confirmed type 2 diabetes